Global Allergy Test Market Size By Type (Assay Kits, Instruments (Immunoassay Analyzer), By Application (Hospital, Diagnostic Laboratory), By Region, And Segment Forecasts, 2023 to 2032

The Global Allergy Test Market was valued at USD 5.9 billion in 2023 and is projected to reach USD 11.3 billion by 2031, growing at a CAGR of 8.4% during the forecast period from 2023 to 2031. The market growth is driven by the rising prevalence of allergic diseases globally, increasing awareness regarding early diagnosis, and the growing demand for advanced and accurate testing methods. Technological advancements in in-vitro diagnostic techniques and point-of-care testing are reshaping the landscape of allergy testing. Additionally, increased healthcare expenditure and proactive government initiatives to manage allergy-related conditions are accelerating market adoption.

Drivers:

Rising Prevalence of Allergic Diseases:

The global incidence of allergic conditions such as rhinitis, asthma, food allergies, and dermatitis is on the rise due to pollution, dietary changes, and genetic factors. This has created a growing need for accurate diagnostic tools to ensure early and effective intervention.

Technological Advancements in Allergy Diagnostics:

New diagnostic methods, including molecular-based allergy tests, component-resolved diagnostics (CRD), and multiplex assays, offer faster, more accurate, and patient-friendly alternatives to traditional skin prick tests. This innovation is fostering higher adoption across clinical settings.

Increasing Healthcare Awareness and Expenditure:

Higher awareness of the impact of allergies on quality of life and the associated economic burden has led to increased healthcare spending. Governments and private healthcare providers are investing in allergy screening programs, driving market expansion.

Restraints:

High Cost of Advanced Allergy Tests:

Advanced testing technologies such as immunoassays and CRDs can be cost-prohibitive, particularly in low- and middle-income countries. This limits access to timely diagnosis in some populations.

Lack of Standardization and Skilled Professionals:

Variations in test interpretation and the shortage of trained allergy specialists in several regions can hamper accurate diagnosis and treatment, constraining market growth.

Opportunity:

Emerging Markets and Untapped Populations:

Rapidly developing healthcare infrastructure in Asia-Pacific, Latin America, and Africa presents immense opportunities for allergy test providers. Expanding awareness and insurance coverage further support penetration in these regions.

Growth in Home-Based and Point-of-Care Testing:

The development of user-friendly, portable diagnostic kits is opening new avenues for allergy testing beyond clinical laboratories. These solutions offer convenience, speed, and accessibility, especially for remote or underserved areas.

Market by System Type Insights:

In 2023, In-Vitro Allergy Tests accounted for the largest market share due to their higher accuracy, safety, and growing usage in large-scale diagnostic laboratories. These tests, such as ELISA and immunoassays, eliminate the risk of allergen exposure and are ideal for patients with severe allergic reactions.

However, Point-of-Care (POC) Testing Systems are expected to witness the fastest growth during the forecast period, driven by consumer preference for faster diagnosis and the expansion of decentralized healthcare models.

Market by End-Use Insights:

The Hospitals and Diagnostic Laboratories segment dominated the market in 2023, representing over 55% of the global share. These settings offer advanced infrastructure, skilled professionals, and a broad range of testing panels.

Meanwhile, the Home Care and Ambulatory Care Centers segment is expected to grow rapidly, fueled by the increasing availability of self-administered allergy tests and the convenience of remote testing solutions.

Market by Regional Insights:

North America led the global allergy test market in 2023, owing to high healthcare awareness, well-established infrastructure, and the presence of major diagnostic companies. The region benefits from widespread allergy education, access to specialty care, and favorable reimbursement policies.

Asia-Pacific is projected to register the highest CAGR during the forecast period, driven by increasing pollution levels, urbanization, rising healthcare investments, and growing prevalence of allergic disorders in countries like India, China, and Japan.

Competitive Scenario:

Key players in the global allergy test market include Thermo Fisher Scientific Inc., Danaher Corporation, Siemens Healthineers, bioMérieux SA, Stallergenes Greer, Omega Diagnostics Group PLC, Eurofins Scientific, HYCOR Biomedical, Quest Diagnostics, and R-Biopharm AG. These companies are actively investing in R&D, expanding product portfolios, and entering strategic partnerships to strengthen market presence.

Scope of Work – Global Allergy Test Market

Report Metric Details

Market Size (2023) USD 5.9 billion

Projected Market Size (2031) USD 11.3 billion

CAGR (2023–2031) 8.4%

Market Segments By System Type (In-Vitro Tests, Skin Tests, POC), By End-Use (Hospitals, Diagnostics Labs, Home Care)

Growth Drivers Rising allergy prevalence, diagnostic tech advancements, healthcare awareness

Opportunities Emerging markets, home-based testing, digital health integration

Key Market Developments:

2023: Thermo Fisher Scientific launched a new range of high-throughput automated allergy analyzers to meet the growing demand for multiplex testing in laboratories.

2024: Siemens Healthineers introduced a portable immunoassay system for POC allergy diagnostics targeting pediatric populations.

2025: Eurofins Scientific partnered with Asian diagnostic centers to expand allergy testing services in underserved regions.

FAQs:

1. What is the current market size of the Global Allergy Test Market?

The market was valued at USD 5.9 billion in 2023.

2. What is the major growth driver of the Global Allergy Test Market?

The rising global prevalence of allergic diseases and the demand for early and accurate diagnosis.

3. Which is the largest region during the forecast period in the Global Allergy Test Market?

North America held the largest market share in 2023.

4. Which segment accounted for the largest market share in Global Allergy Test Market?

The In-Vitro Allergy Tests segment led the market in 2023.

5. Who are the key market players in the Global Allergy Test Market?

Major players include Thermo Fisher Scientific, Danaher, Siemens Healthineers, bioMérieux, and Eurofins Scientific.